Statins are potential anticancerous agents AK Altwairgi Oncology reports 33 (3), 1019-1039, 2015 | 144 | 2015 |
Discordance Between Conclusions Stated in the Abstract and Conclusions in the Article: Analysis of Published Randomized Controlled Trials of Systemic Therapy in Lung Cancer AK Altwairgi, CM Booth, WM Hopman, TD Baetz Journal of Clinical Oncology 30 (28), 3552-3557, 2012 | 56 | 2012 |
The epidemiology of primary central nervous system tumors at the National Neurologic Institute in Saudi Arabia: a ten‐year single‐institution study A Almutrafi, Y Bashawry, W AlShakweer, M Al-Harbi, A Altwairgi, ... Journal of Cancer Epidemiology 2020 (1), 1429615, 2020 | 38 | 2020 |
Real-world impact of granulocyte-colony stimulating factor on febrile neutropenia AK Altwairgi, WM Hopman, M Mates Current Oncology 20 (3), e171, 2013 | 36 | 2013 |
Atorvastatin in combination with radiotherapy and temozolomide for glioblastoma: a prospective phase II study AK Altwairgi, WA Alghareeb, FH AlNajjar, H Alhussain, E Alsaeed, ... Investigational New Drugs 39, 226-231, 2021 | 34 | 2021 |
Atypical teratoid/rhabdoid tumor of the sellar region in an adult with long survival: case report and review of the literature MH Almalki, A Alrogi, A Al-Rabie, S Al-Dandan, A Altwairgi, Y Orz Journal of Clinical Medicine Research 9 (3), 216, 2017 | 29 | 2017 |
Management and treatment recommendations for World Health Organization Grade III and IV gliomas AK Altwairgi, S Raja, M Manzoor, S Aldandan, E Alsaeed, A Balbaid, ... International Journal of Health Sciences 11 (3), 54, 2017 | 24 | 2017 |
Saudi lung cancer management guidelines 2017 AR Jazieh, K Al Kattan, A Bamousa, A Al Olayan, A Abdelwarith, J Ansari, ... Annals of Thoracic Medicine 12 (4), 221-246, 2017 | 13 | 2017 |
Quality of reporting of chemotherapy compliance in randomized controlled trials of breast cancer treatment AK Altwairgi, AH Alfakeeh, WM Hopman, WR Parulekar Japanese Journal of Clinical Oncology 45 (6), 520-526, 2015 | 12 | 2015 |
Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations E Göker, A Altwairgi, A Al-Omair, A Tfayli, E Black, H Elsayed, U Selek, ... Lung Cancer 158, 60-73, 2021 | 11 | 2021 |
Phase II study of atorvastatin in combination with radiotherapy and temozolomide In patients with glioblastoma (ART): Interim analysis report AK Altwairgi, W Alghareeb, F Alnajjar, E Alsaeed, A Balbaid, H Alhussain, ... Annals of Oncology 27, vi113, 2016 | 7 | 2016 |
Outcome of patients with glioblastoma in Saudi Arabia: Single center experience AK Altwairgi, W Algareeb, G Yahya, AM Maklad, MM Aly, W Al Shakweer, ... Molecular and Clinical Oncology 4 (5), 756-762, 2016 | 6 | 2016 |
Phase II study of atorvastatin in combination with radiotherapy and temozolomide in patients with glioblastoma (ART): Final analysis report AK Altwairgi, F Alnajjar, H Alhussain, E Alsaeed, A Balbaid, S Aldandan, ... Annals of Oncology 30, ix20, 2019 | 4 | 2019 |
Impact of concurrent (CON) and sequential (SEQ) radiotherapy (RT) with adjuvant aromatase inhibitors (AI) in early-stage breast cancer (EBC): NCIC CTG MA. 27. AK Altwairgi, W Parulekar, JAW Chapman, LE Shepherd, KI Pritchard, ... Journal of Clinical Oncology 30 (15_suppl), 500-500, 2012 | 3 | 2012 |
Unusually long survival of an adult patient with atypical teratoid/rhabdoid tumor of the sellar region: A follow-up report M Almalki, A Altwairgi, Y Orz Ibnosina Journal of Medicine and Biomedical Sciences 12 (01), 53-56, 2020 | 2 | 2020 |
Phase II study of atorvastatin in combination with radiotherapy and temozolomide in patients with glioblastoma. AK Altwairgi, WA Alghareeb, FH AlNajjar, M Mubasher, H Alhussain, ... Journal of Clinical Oncology 32 (15_suppl), TPS2102-TPS2102, 2014 | 2 | 2014 |
Treatment patterns and outcomes among elderly glioblastoma patients in Riyadh, Saudi Arabia A Marie, A Maklad, A AlTwairgi, M Aly, A Elyamany, W AlShaqweer, ... OncoTargets and therapy, 135-144, 2022 | 1 | 2022 |
Outcome of patients with glioblastoma in Saudi Arabia: Single center experience. AK Altwairgi, WA Alghareeb, GM Yahya, W AlShakweer, A Elyamany Journal of Clinical Oncology 33 (15_suppl), e13047-e13047, 2015 | 1 | 2015 |
Review of practice patterns of primary granulocyte-colony stimulating factor prophylaxis and impact on febrile neutropenia rate and chemotherapy delivery in patients with early … M Mates, W Hopman, AK Altwairgi Journal of Clinical Oncology 30 (15_suppl), e19541-e19541, 2012 | 1 | 2012 |
Characterization of patients who received further adjuvant endocrine therapy after 5 years of aromatase inhibitors (AIs): NCIC CTG MA 27. SE Vogl, AK Altwairgi, JAW Chapman, L Zhu, LE Shepherd, PE Goss, ... Journal of Clinical Oncology 30 (15_suppl), e11005-e11005, 2012 | 1 | 2012 |